PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption
Status:
NOT_YET_RECRUITING
Trial end date:
2026-05-28
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue under controlled alcohol-exposure conditions. Pharmacokinetic sampling, onset assessments, and safety evaluations will be conducted throughout the study.